These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19954719)

  • 1. Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose.
    Tanaka H; Oki E; Tsuruga K; Yashiro T; Hanada I; Ito E
    Clin Nephrol; 2009 Dec; 72(6):430-6. PubMed ID: 19954719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective treatment of young patients with pediatric-onset, long-standing lupus nephritis with tacrolimus given as a single daily dose: an open-label pilot study.
    Tanaka H; Oki E; Tsugawa K; Nonaka K; Suzuki K; Ito E
    Lupus; 2007; 16(11):896-900. PubMed ID: 17971363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: a prospective study in daily clinical practice.
    Tanaka H; Watanabe S; Aizawa-Yashiro T; Oki E; Kumagai N; Tsuruga K; Ito E
    Nephron Clin Pract; 2012; 121(3-4):c165-73. PubMed ID: 23327881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical assessment of tacrolimus therapy in lupus nephritis: one-year follow-up study in a single center.
    Asamiya Y; Uchida K; Otsubo S; Takei T; Nitta K
    Nephron Clin Pract; 2009; 113(4):c330-6. PubMed ID: 19729969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mizoribine treatment of young patients with severe lupus nephritis: a clinicopathologic study by the tohoku pediatric study group.
    Tanaka H; Oki E; Tsuruga K; Sato N; Matsukura H; Matsunaga A; Kondo Y; Suzuki J
    Nephron Clin Pract; 2008; 110(2):c73-9. PubMed ID: 18758186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of tacrolimus-based immunosuppressive treatment for patients with paediatric-onset lupus nephritis.
    Tanaka H; Aizawa T; Endo M
    Nephrology (Carlton); 2024 Dec; 29(12):901-908. PubMed ID: 39429105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus versus cyclophosphamide as treatment for diffuse proliferative or membranous lupus nephritis: a non-randomized prospective cohort study.
    Wang S; Li X; Qu L; Wang R; Chen Y; Li Q; He X; Zhang X; Wang H; Wu J; Xu Y; Chen J
    Lupus; 2012 Aug; 21(9):1025-35. PubMed ID: 22570338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritis.
    Tanaka H; Aizawa T; Watanabe S; Oki E; Tsuruga K; Imaizumi T
    Lupus; 2014 Jul; 23(8):813-8. PubMed ID: 24651669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus is effective for lupus nephritis patients with persistent proteinuria.
    Uchino A; Tsukamoto H; Nakashima H; Yoshizawa S; Furugo I; Mitoma H; Oryoji K; Shimoda T; Niiro H; Tada Y; Yano T; Nonaka T; Oishi R; Akashi K; Horiuchi T
    Clin Exp Rheumatol; 2010; 28(1):6-12. PubMed ID: 20346231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Laboratory and morphologic parameters in patients with lupus nephritis].
    Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
    Szeto CC; Kwan BC; Lai FM; Tam LS; Li EK; Chow KM; Gang W; Li PK
    Rheumatology (Oxford); 2008 Nov; 47(11):1678-81. PubMed ID: 18753192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
    Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients.
    Tanaka H; Tsugawa K; Oki E; Suzuki K; Ito E
    Clin Rheumatol; 2008 Jan; 27(1):85-9. PubMed ID: 17483980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cyclosporine A on serum and urinary soluble interleukin-2 receptor in patients with lupus nephritis.
    Tang Z; Zhang J; Zhang S; Li L
    Chin Med J (Engl); 1997 Sep; 110(9):686-9. PubMed ID: 9642325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of serum C3 and CH50 levels as markers of disease-activity and indicators of efficacy of treatment of lupus nephritis in childhood].
    Ibe M; Kuriyama T; Mori M; Mitsuda T; Aihara Y; Yokota S
    Ryumachi; 1994 Aug; 34(4):715-24. PubMed ID: 7974022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis.
    Boumpas DT; Furie R; Manzi S; Illei GG; Wallace DJ; Balow JE; Vaishnaw A;
    Arthritis Rheum; 2003 Mar; 48(3):719-27. PubMed ID: 12632425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study.
    Mok CC; To CH; Yu KL; Ho LY
    Lupus; 2013 Oct; 22(11):1135-41. PubMed ID: 23995863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.
    Li X; Li H; Chen J; He Q; Lv R; Lin W; Li Q; He X; Qu L; Suya W
    Nephrol Dial Transplant; 2008 Jun; 23(6):1919-25. PubMed ID: 17911091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.